4.7 Review

Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy and esophagectomy for the treatment of esophageal and gastroesophageal carcinoma-A systematic review and meta-analysis

Related references

Note: Only part of the references are listed.
Article Oncology

Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study)

Maarten C. C. M. Hulshof et al.

Summary: In definitive chemoradiation for esophageal cancer, escalating radiation dose up to 61.6 Gy to the primary tumor did not significantly improve local tumor control compared to 50.4 Gy. The absence of a dose-effect was observed in both adenocarcinoma and squamous cell carcinoma.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Review Gastroenterology & Hepatology

Epidemiology of esophageal cancer: update in global trends, etiology and risk factors

Dustin J. Uhlenhopp et al.

CLINICAL JOURNAL OF GASTROENTEROLOGY (2020)

Article Medicine, General & Internal

RoB 2: a revised tool for assessing risk of bias in randomised trials

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2019)

Article Cardiac & Cardiovascular Systems

Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma

Arianna Barbetta et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2018)

Review Medicine, General & Internal

Non-surgical versus surgical treatment for oesophageal cancer

Lawrence M. J. Best et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)

Review Gastroenterology & Hepatology

Esophageal cancer: epidemiology, pathogenesis and prevention

Sarah B. Umar et al.

NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2008)